Audun Tornes
Technik-/Wissenschafts-/F&E-Leiter bei ULTIMOVACS ASA
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Hans Vassgård Eid | M | 57 | - | |
| Anne Hovi Worsøe | F | 60 | 3 Jahre | |
| Gudrun Trøite | M | - | - | |
| Carlos de Sousa | M | 66 | 4 Jahre | |
| Olav Steinnes | M | 67 |
Inven2 AS
 Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 13 Jahre |
| Antonius Berkien | M | 56 | 4 Jahre | |
| Ingunn Hagen Westgaard | F | - | - | |
| Haakon Stenrod | M | 44 | 4 Jahre | |
| Jens Bjørheim | M | - | - | |
| Øivind Foss | M | - | - | |
| Kari Grønås | F | 59 | 5 Jahre | |
| Gustav Gaudernack | M | - | - | |
| Ole Kristian Hjelstuen | M | - |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 12 Jahre |
| Henrik Schüssler | M | 61 | 9 Jahre | |
| Ole Kristian Skaar | M | - |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 13 Jahre |
| Jónas Einarsson | M | 67 | 13 Jahre | |
| Mc Callion Orla | M | - | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jostein Christian Dalland | M | 55 |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Norwegen | 18 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Audun Tornes
- Persönliches Netzwerk
